Researchers at Stanford University have developed a novel 3D printing method, enabling multiple printheads to collaboratively pattern materials from multiple directions, an 'inwards-out' approach that overcomes previous limitations.
Stanford researchers have discovered the first of its kind gene therapy vector to treat eye diseases of the non-pigmented ciliary epithelium cells (NPCECs).
Researchers at Stanford have combined 3D printing and pyrolysis to produce a robust and biocompatible high resolution micro-array patch (MAP) for transdermal drug delivery.
Stem cells are generally influenced by a microenvironmental niche, typically comprised of epithelial and mesenchymal cells and extracellular substrates. Many attempts have been made to produce culture systems that mimic normal intestinal epithelial growth and differentiation.
Patients with celiac disease have a pathological reaction to gluten and have either HLA-DQ2+ (90%) or HLA-DQ8+, but expression of these MHC class II haplotypes is not sufficient and other factors are necessary for the development of celiac sprue.
Clinician-scientists at Stanford have proposed a WNT formulation that, when used in combination with a first-of-its-kind normothermic perfusion device, reconditions marginal organs and enables their safe transplantation.
Brief Description: Inventors at Stanford have developed a novel fiber-optic technology to achieve unprecedented sensitivity and immunity to motion artifacts that can be used in freely moving animals.
Inventors at Stanford have developed a novel strategy to perform concurrent fluorescence measurements of multiple biological parameters in freely moving and head-restrained animals.
Stanford researchers have identified an appropriate method and dosage for radiotherapy-based noninvasive lung volume reduction to treat severe emphysema.
Stanford researchers have developed a method for manufacturing high quality multifunctional soft electronic fibers based on conventional microfabrication techniques.
Stanford researchers in the Zhao Lab have developed a mechanical thrombectomy device for Pulmonary Embolism (PE) that mechanically debulks and reduces volume of large clots without causing fragmentation.
Stanford researchers at the Zhao Lab have designed milli-spinner thrombectomy devices that mechanically debulk clots by safely shredding the clots for fast and complete clot removal.
Stanford researchers have developed a set of intervention videos to improve mindsets about osteoarthritis and exercise, which was proven in a randomized clinical trial to increase physical activity levels and overall health and wellbeing in an individual.